Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
The consolidated opinions of the Committees for Risk Assessment and Socio-economic Analysis are now available for:
(*) use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -; CAS -) by Lonza Biologics Porriño, SL. and Lonza Biologics, plc.;
(*) two uses (use 1, use 2) of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -; CAS -) by Wallac Oy;
(*) use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -; CAS -) by Rentschler Biopharma SE;
(*) use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -; CAS -) by Teva Baltics UAB; and
(*) use of 4-nonylphenol, branched and linear, ethoxylated (EC -; CAS -) by Sekisui S-lec BV Roermond.
Link to Opinions
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions